By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Research Digest > New Studies > Vitamin D Directly Controls Dopamine Production in Human Brain Neurons According to Cui et al. Research
New StudiesResearch Digest

Vitamin D Directly Controls Dopamine Production in Human Brain Neurons According to Cui et al. Research

GMJ
Last updated: 27/05/2026 17:41
By
GMJ Research Desk
Share
6 Min Read
Brain neurons with vitamin D receptors controlling dopamine production
New research reveals vitamin D receptors are physically present in dopamine-producing brain neurons, where they directly control neurotransmitter synthesis and neuronal survival. Studies show activation can double dopamine cell production, with implications for Parkinson's disease prevention. — Photo: cottonbro studio / Pexels
SHARE
🎧 Listen to this article5:23 min · 729 words · GMJ Audio
4 min read|729 words

Vitamin D operates far beyond its established role in bone health, directly controlling dopamine production within the brain’s substantia nigra—the region that degenerates in Parkinson’s disease, according to research by Cui et al. published in Neuroscience. The research demonstrates that vitamin D receptors are physically present inside dopamine-producing neurons, where they regulate gene targets that determine both dopamine synthesis and neuronal survival.

Contents
      • Vitamin D’s Impact on Dopamine Neuron Development
  • Nuclear Receptors Located in Dopamine-Producing Neurons
  • Vitamin D Activation Doubles Dopamine Cell Production
  • Enhanced Synaptic Connectivity and Functional Release
  • Implications for Parkinson’s Disease Prevention
    • Key takeaways
  • Frequently asked questions
    • How does vitamin D affect brain function beyond bone health?
    • What is the optimal vitamin D level for brain health?
    • Can vitamin D supplementation prevent Parkinson’s disease?
100%+
increase in dopamine-producing cells when vitamin D receptors are activated (Cui et al., Neuroscience, 2015)

Vitamin D’s Impact on Dopamine Neuron Development

Cell count changes in dopamine-producing neurons, by treatment condition

VDR + Vitamin D
200%
VDR Overexpression
130%
Control Group

100%

Source: Cui et al., Neuroscience, 2015 | Georgian Medical Journal News

Nuclear Receptors Located in Dopamine-Producing Neurons

Research by Cui and colleagues published in Neuroscience (2013) used immunohistochemistry to map vitamin D receptors (VDR) directly within human and rat brain tissue. The receptors are located in the nucleus of tyrosine hydroxylase-positive neurons—the specific cells that synthesize dopamine in the substantia nigra.

Submit Your Paper
GMJ_Submit_Banner

In developing rat brains, vitamin D receptors emerge between embryonic days 12 and 15, according to the Cui et al. research published in Neuroscience.

🎙️ Related Podcast Episodes
🎧 #37 | GMJ Podcast | NAD⁺ Injections and “NAD Boosters” — Public Health Risks and Regulatory Implications · 20m
🎧 #52 | GMJ Podcast | Health and Migration Knowledge Hub — A Global Resource for Evidence-Based Practice · 17m
🎧 #51 | GMJ Podcast | Global Health, Migration, and Health Systems Resilience · 14m
🎧 #31 | GMJ Podcast | Daily Multivitamins and Biological Ageing — COSMOS Trial · 21m
🎧 #30 | GMJ Podcast | Global Health: Why Health Systems Matter · 15m

Vitamin D Activation Doubles Dopamine Cell Production

When vitamin D activates these neural receptors, the effects on dopamine production are measurable and significant. Cui et al.’s 2015 study in Neuroscience demonstrated that 1,25-dihydroxyvitamin D3 treatment in neuroblastoma cells overexpressing VDR increased tyrosine hydroxylase expression—the rate-limiting enzyme in dopamine synthesis.

The research team found that tyrosine hydroxylase-positive cell counts more than doubled compared to controls. This effect proved both dose- and time-dependent, with higher concentrations and longer exposure periods yielding greater increases in dopamine production capacity.

Further analysis revealed that vitamin D treatment decreased expression of NEUROG2, an immature neuronal marker, indicating that cells were being directed toward a mature dopaminergic phenotype rather than remaining undifferentiated, according to the Cui et al. study.

Enhanced Synaptic Connectivity and Functional Release

Work by Pertile et al., published in the Journal of Neurochemistry (2023), expanded understanding of vitamin D’s neural effects beyond simple dopamine production. The research demonstrated that vitamin D treatment increased neurite outgrowth, neurite branching, and the number and distribution of presynaptic protein puncta in dopaminergic cells.

The neurons showed increased functional dopamine release, according to the Pertile et al. study, indicating that vitamin D’s benefits extend to actual neurotransmitter function rather than just cellular markers. The cells were building longer processes and forming more synaptic connections.

Implications for Parkinson’s Disease Prevention

These findings carry implications for neurodegenerative disease prevention, particularly Parkinson’s disease, which specifically targets dopamine-producing neurons in the substantia nigra. Research published in FASEB Journal (2018) by Pertile et al. supports vitamin D’s neuroprotective role in dopaminergic systems.

The dose- and time-dependent nature of vitamin D’s effects, as demonstrated by Cui et al., suggests potential importance for maintaining adequate vitamin D levels throughout life.

Tyrosine hydroxylase-positive cell count more than doubled when vitamin D receptors were activated, with effects that were both dose- and time-dependent.

— Cui et al., Neuroscience Research Team (Neuroscience, 2015)

Key takeaways

  • Vitamin D receptors are physically present in dopamine-producing brain neurons (Cui et al., Neuroscience, 2013)
  • Activation increases dopamine synthesis by over 100% in laboratory studies (Cui et al., Neuroscience, 2015)
  • Vitamin D enhances both neuron survival and synaptic connectivity (Pertile et al., Journal of Neurochemistry, 2023)
  • Effects are dose- and time-dependent (Cui et al., Neuroscience, 2015)
  • Research findings may inform Parkinson’s disease prevention strategies

Frequently asked questions

How does vitamin D affect brain function beyond bone health?

According to Cui et al. (Neuroscience, 2013), vitamin D receptors are located directly inside dopamine-producing neurons in the brain’s substantia nigra. When activated, they control genes that increase dopamine synthesis and improve neuronal survival.

What is the optimal vitamin D level for brain health?

While the Cui et al. studies demonstrate dose-dependent effects, specific optimal blood levels for neuroprotection require further research. The research shows that higher concentrations and longer exposure periods yield greater benefits for dopamine neuron function.

Can vitamin D supplementation prevent Parkinson’s disease?

The laboratory studies by Cui et al. and Pertile et al. show vitamin D enhances dopamine neuron survival and function. While promising, clinical trials are needed to establish definitive protective effects against Parkinson’s disease in humans.

The identification of vitamin D as a direct regulator of dopamine neuron function, as demonstrated by Cui et al. and Pertile et al., opens new avenues for research into neurodegenerative diseases that affect these critical brain regions.

Source: Cui et al., Neuroscience, 2013

Was this article helpful?

Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →

Related Coverage

Eye-tracking study reveals depression shifts children's attention to sad facesJul 14, 2026
Correction issued for MAGE-A4/A8 immunotherapy trial in advanced solid tumoursJul 14, 2026
Jackfruit-derived biomaterial shows promise in reversing severe gum disease damageJul 14, 2026
Scientists Reprogram Brain Immune Cells to Combat Alzheimer's DiseaseJul 14, 2026
Related reference
  • Neuroblastoma · Condition
  • Vitamin D · Ingredient
PG
Written by
Prof. Giorgi Pkhakadze, MD, MPH, PhD
Editor-in-Chief, GMJ News
Full profile →  ·  ORCID 0000-0001-7609-4515
Medical disclaimer. This article is health journalism intended for general information. It is not medical advice and is not a substitute for consultation with a qualified healthcare professional. Always seek your physician's advice regarding any medical condition.
Medically reviewed by Prof. Giorgi Pkhakadze, MD, MPH, PhD. Spotted an error? Contact the editorial team.
Get the GMJ News digest
Evidence-based health journalism in your inbox. No spam; unsubscribe anytime.
TAGGED:brain healthdopamineneuroscienceParkinson's diseasevitamin D
Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByGMJ Research Desk
Follow:
GMJ Research Desk is part of GMJ News, the newsroom of the Georgian Medical Journal (gmj.ge), published by the Public Health Institute of Georgia. Every article is editorially reviewed before publication.
Leave a Comment Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
International Survey Reveals Critical Gaps in Cardio-Oncology Training Despite Rising Clinical Demand

An international survey presented at ESC Cardio-Oncology 2026 has identified substantial deficiencies…

UK Guidance on Inadvertent Vaccination in Pregnancy: What Healthcare Providers Need to Know

UK health authorities have published guidance for healthcare professionals managing inadvertent live…

UK Charity Maggie’s to Open Two New Cancer Care Centres in Coventry and Birmingham

Charity Maggie's will open two new dedicated cancer care centres in Coventry…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Microscopic image of microglia brain immune cells responding to amyloid and tau proteinsPhoto by BUDDHI Kumar SHRESTHA on Unsplash (Unsplash License)
New StudiesResearch Digest

Brain immune cells reveal why some people resist dementia despite tau tangles

By
GMJ Research Desk
12/06/2026
Colorful array of whole plant foods including vegetables, fruits, nuts and grains representing healthful plant-based dietIllustrative image · Photo by Fuzzy Rescue on Pexels (Pexels License)
Clinical UpdatesExplainersNew StudiesPerspectivesPracticeResearch Digest

Plant-Based Diet Quality More Important Than Processing Level for Chronic Disease Prevention

By
GMJ Practice Desk
02/07/2026
Hospital corridor with medical staff highlighting COVID-19 summer surge surveillance data
Data & NumbersGlobal HealthPolicy & SystemsResearch Digest

UK Reports Sharp Summer COVID-19 Rise as Hospitalizations Jump 24% in One Week

By
GMJ Research Desk
03/06/2026
Chart showing dramatic variation in multimorbidity prevalence estimates using different measurement approachesIllustrative image · Photo by Jess Loiterton on Pexels (Pexels License)
New StudiesResearch Digest

Different Ways of Measuring Multiple Chronic Diseases Yield Vastly Different Results, UK Biobank Study Shows

By
GMJ Research Desk
04/07/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up